CompaniesNeuron23

Neuron23

active
South SF, CA, United States
Founded 2018
Website
About

AI-drug discovery

Areas of Focus

Categories

AI FocusedBiotech
Team (21)
Chief Financial Officer
Chief Financial Officer
Neuron23
executive
Chief Medical Officer
Chief Medical Officer
Neuron23
executive
Chief Scientific Officer
Chief Scientific Officer
Neuron23
executive
Director at Andera Partners
Director at Andera Partners
Neuron23
team_member
Executive Chairman, Perfuse Therapeutics
Executive Chairman, Perfuse Therapeutics
Neuron23
board_chair
Executive Vice President, Operations
Executive Vice President, Operations
Neuron23
executive
View all 21 team members →
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

6

As Collaborator

0

Total Enrollment

562

By Phase

PHASE1: 4PHASE2: 1

By Status

RECRUITING: 2COMPLETED: 2TERMINATED: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT04893083
NCT06680830
Hover over trial bars to see details

Recent Trials

NCT06900751Lead Sponsor
A Study to Assess NEU-627 in Healthy Participants
PHASE1Recruiting
96 participants
Started: Jun 2, 2025 · Completed: Nov 30, 2025
NCT06680830Lead Sponsor
A Phase 2 Study of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
PHASE2Recruiting
150 participants
Started: Jan 17, 2025 · Completed: Sep 30, 2027
NCT06500442Lead Sponsor
A Study to Assess NEU-111 in Healthy Participants
PHASE1Completed
64 participants
Started: Sep 17, 2024 · Completed: Feb 22, 2025
NCT05755191Lead Sponsor
A Study to Assess NEU-411 in Healthy Participants
PHASE1Completed
147 participants
Started: May 13, 2023 · Completed: Jun 3, 2024
NCT05633745Lead Sponsor
A Study to Assess NEU-723 in Healthy Participants
PHASE1Terminated
40 participants
Started: Jan 30, 2023 · Completed: Jun 30, 2023
View all 6 trials →
Locations (1)
Headquarters
South SF, CA, United States
Map

Loading map...